SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: A proposed standardization framework

Rudolf A. Werner, Lilja B. Solnes, Mehrbod S. Javadi, Alexander Weich, Michael A. Gorin, Kenneth J. Pienta, Takahiro Higuchi, Andreas K. Buck, Martin G. Pomper, Steven P. Rowe, Constantin Lapa

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.

Original languageEnglish
Pages (from-to)1085-1091
Number of pages7
JournalJournal of Nuclear Medicine
Volume59
Issue number7
DOIs
Publication statusPublished - Jul 1 2018
Externally publishedYes

Fingerprint

Somatostatin Receptors
Peptide Receptors
Neuroendocrine Tumors
Radioisotopes
Positron-Emission Tomography
Patient Selection

Keywords

  • Ga-DOTATATE/-TOC
  • Neuroendocrine tumor
  • Peptide receptor radionuclide therapy
  • PET
  • PRRT
  • RADS
  • Somatostatin receptor
  • SSTR

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging

Cite this

SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates : A proposed standardization framework. / Werner, Rudolf A.; Solnes, Lilja B.; Javadi, Mehrbod S.; Weich, Alexander; Gorin, Michael A.; Pienta, Kenneth J.; Higuchi, Takahiro; Buck, Andreas K.; Pomper, Martin G.; Rowe, Steven P.; Lapa, Constantin.

In: Journal of Nuclear Medicine, Vol. 59, No. 7, 01.07.2018, p. 1085-1091.

Research output: Contribution to journalArticle

Werner, RA, Solnes, LB, Javadi, MS, Weich, A, Gorin, MA, Pienta, KJ, Higuchi, T, Buck, AK, Pomper, MG, Rowe, SP & Lapa, C 2018, 'SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: A proposed standardization framework', Journal of Nuclear Medicine, vol. 59, no. 7, pp. 1085-1091. https://doi.org/10.2967/jnumed.117.206631
Werner, Rudolf A. ; Solnes, Lilja B. ; Javadi, Mehrbod S. ; Weich, Alexander ; Gorin, Michael A. ; Pienta, Kenneth J. ; Higuchi, Takahiro ; Buck, Andreas K. ; Pomper, Martin G. ; Rowe, Steven P. ; Lapa, Constantin. / SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates : A proposed standardization framework. In: Journal of Nuclear Medicine. 2018 ; Vol. 59, No. 7. pp. 1085-1091.
@article{dd7fd622ebc348f9b08e621ccf9206fc,
title = "SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates: A proposed standardization framework",
abstract = "Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.",
keywords = "Ga-DOTATATE/-TOC, Neuroendocrine tumor, Peptide receptor radionuclide therapy, PET, PRRT, RADS, Somatostatin receptor, SSTR",
author = "Werner, {Rudolf A.} and Solnes, {Lilja B.} and Javadi, {Mehrbod S.} and Alexander Weich and Gorin, {Michael A.} and Pienta, {Kenneth J.} and Takahiro Higuchi and Buck, {Andreas K.} and Pomper, {Martin G.} and Rowe, {Steven P.} and Constantin Lapa",
year = "2018",
month = "7",
day = "1",
doi = "10.2967/jnumed.117.206631",
language = "English",
volume = "59",
pages = "1085--1091",
journal = "Journal of Nuclear Medicine",
issn = "0161-5505",
publisher = "Society of Nuclear Medicine Inc.",
number = "7",

}

TY - JOUR

T1 - SSTR-RADS version 1.0 as a reporting system for SSTR PET imaging and selection of potential PRRT candidates

T2 - A proposed standardization framework

AU - Werner, Rudolf A.

AU - Solnes, Lilja B.

AU - Javadi, Mehrbod S.

AU - Weich, Alexander

AU - Gorin, Michael A.

AU - Pienta, Kenneth J.

AU - Higuchi, Takahiro

AU - Buck, Andreas K.

AU - Pomper, Martin G.

AU - Rowe, Steven P.

AU - Lapa, Constantin

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.

AB - Reliable standards and criteria for somatostatin receptor (SSTR) PET are still lacking. We herein propose a structured reporting system on a 5-point scale for SSTR PET imaging, titled SSTR-RADS version 1.0, which might serve as a standardized assessment for both diagnosis and treatment planning in neuroendocrine tumors. SSTR-RADS could guide the imaging specialist in interpreting SSTR PET scans, facilitate communication with the referring clinician so that appropriate workup for equivocal findings is pursued, and serve as a reliable tool for patient selection for planned peptide receptor radionuclide therapy.

KW - Ga-DOTATATE/-TOC

KW - Neuroendocrine tumor

KW - Peptide receptor radionuclide therapy

KW - PET

KW - PRRT

KW - RADS

KW - Somatostatin receptor

KW - SSTR

UR - http://www.scopus.com/inward/record.url?scp=85049393958&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049393958&partnerID=8YFLogxK

U2 - 10.2967/jnumed.117.206631

DO - 10.2967/jnumed.117.206631

M3 - Article

C2 - 29572257

AN - SCOPUS:85049393958

VL - 59

SP - 1085

EP - 1091

JO - Journal of Nuclear Medicine

JF - Journal of Nuclear Medicine

SN - 0161-5505

IS - 7

ER -